Natural products (NPs) have played an important role in medication development, particularly in the treatment of cancer and infectious disorders, but also in other therapeutic areas such as neurodegenerative disease. In comparison to traditional synthetic compounds, NPs have unique properties that provide both benefits and problems to the drug discovery process. The scaffold variety and structural complexity of NPs are immense. Many beneficial medicinal herbs can be used to treat dementia and Alzheimer's disease. Flavonoids and alkaloids, for example, have been demonstrated to have powerful anti-effects. Alzheimer's As a result, more research into medicinal plants and the discovery of new active chemicals to combat Alzheimer's disease is required.
- Molecular Structure and Modifications
- Natural Products as Therapeutics
- Small Molecule Natural Products
- Medicinal Plants
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States